Private equity firm Bain Capital agreed to buy Italian chemicals maker Italmatch from french investor Ardian, the companies announced on Thursday, defeating rival bids from KKR and Cinven.
The firm did not disclose a deal value, but sources familiar with the matter told Reuters on Wednesday that Bain will pay around 700 million euros ($808.71 million) to take control of the Genoa-based company.
Italmatch has been controlled by Ardian since 2014 and Bain said in a statement that under Ardian ownership, Italmatch has more than doubled its sales over the past four years.
Bain Capital Managing Director Ivano Sessa said the firm is seeking to grow Italmatch organically and through acquisitions.
Ardian had hired Goldman Sachs and BNP Paribas to kick off an auction process in the second quarter, which mainly drew interest from private equity investors, including KKR, Bain and Cinven.
It started sounding out potential bidders earlier this year to take advantage of high sector valuations.
Italmatch, founded in 1997 through a management buyout of phosphorus derivatives maker Saffa, has expanded its global footprint in recent years through a series of acquisitions.
By Sangameswaran S
This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.
The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.
Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.